hydralazine has been researched along with Autoimmune Disease in 30 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man was diagnosed as having constrictive pericarditis 17 months after a typical hydralazine-induced autoimmune syndrome." | 8.79 | Hydralazine-induced constrictive pericarditis. ( el Gamal, MI; Franssen, CF; Gans, RO; Hoorntje, SJ, 1996) |
| "A 59-year-old man was diagnosed as having constrictive pericarditis 17 months after a typical hydralazine-induced autoimmune syndrome." | 4.79 | Hydralazine-induced constrictive pericarditis. ( el Gamal, MI; Franssen, CF; Gans, RO; Hoorntje, SJ, 1996) |
| "Recurrent episodes of postprandial hypoglycemic symptoms culminated in hypoglycemic coma in a hypertensive but otherwise healthy man while he was taking hydralazine." | 4.78 | Reactive hypoglycemic coma due to insulin autoimmune syndrome: case report and literature review. ( Burch, HB; Clement, S; Landry, F; Sokol, MS, 1992) |
| "An 82-year-old woman developed symptomatic reactive hypoglycemia in the same year she developed a lupus-like syndrome, probably secondary to the administration of procainamide or hydralazine." | 3.66 | Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus. ( Blackshear, PJ; Kahn, CR; Kriauciunas, KA; Rotner, HE, 1983) |
| "The immunological side-effects under treatment with antihypertensive drugs are mainly limited to autoimmunity and autoimmune disease caused by alpha-methyldopa and hydralazine." | 3.66 | Immunological side-effects of antihypertensive drugs. ( Holm, G, 1979) |
| "Hydralazine was stopped and the patient gradually became asymptomatic." | 1.29 | Effect of acute cytomegalovirus infection on drug-induced SLE. ( Geltner, D; Schattner, A; Sthoeger, Z, 1994) |
| "Hydralazine treatment did not alter cell-mediated immune responses." | 1.26 | Prospective study of immunologic effects of hydralazine in hypertensive patients. ( Adams, LE; Foad, B; Hess, EV; Litwin, A; Loggie, JH; Zimmer, H, 1981) |
| "Hydralazine treatment did not alter cell-mediated immune responses and hydralazine antibodies were not detected." | 1.26 | Immunologic effects of hydralazine in hypertensive patients. ( Adams, LE; Hess, EV; Litwin, A; Zimmer, H, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (80.00) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 1 (3.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Q | 1 |
| Guo, Y | 1 |
| Guo, L | 1 |
| Liao, S | 1 |
| Zhao, C | 1 |
| Wang, S | 1 |
| Liu, HF | 1 |
| VACHTENHEIM, J | 1 |
| YAMAGUCHI, S | 1 |
| KOMIYA, M | 1 |
| Richardson, B | 3 |
| Blackshear, PJ | 1 |
| Rotner, HE | 1 |
| Kriauciunas, KA | 1 |
| Kahn, CR | 1 |
| Litwin, A | 2 |
| Adams, LE | 2 |
| Zimmer, H | 2 |
| Foad, B | 1 |
| Loggie, JH | 1 |
| Hess, EV | 3 |
| Holborow, EJ | 1 |
| Schoen, RT | 1 |
| Trentham, DE | 1 |
| Parker, CW | 1 |
| Schattner, A | 1 |
| Sthoeger, Z | 1 |
| Geltner, D | 1 |
| Nässberger, L | 1 |
| Franssen, CF | 1 |
| el Gamal, MI | 1 |
| Gans, RO | 1 |
| Hoorntje, SJ | 1 |
| Holm, G | 1 |
| Pinnas, JL | 1 |
| Fenster, PE | 1 |
| Burch, HB | 1 |
| Clement, S | 1 |
| Sokol, MS | 1 |
| Landry, F | 1 |
| Cornacchia, E | 2 |
| Golbus, J | 2 |
| Maybaum, J | 2 |
| Strahler, J | 2 |
| Hanash, S | 2 |
| Hughes, JD | 1 |
| Rubin, LJ | 1 |
| Spears, CJ | 1 |
| Batchelor, JR | 1 |
| Rubin, RL | 1 |
| Tang, FL | 1 |
| Chan, EK | 1 |
| Pollard, KM | 1 |
| Tsay, G | 1 |
| Tan, EM | 3 |
| Cush, JJ | 1 |
| Goldings, EA | 1 |
| Perry, HM | 1 |
| Chaplin, H | 1 |
| Carmody, S | 1 |
| Haynes, C | 1 |
| Frei, C | 1 |
| Losada, M | 1 |
| Meruane, J | 1 |
| Braverman, IM | 1 |
| Maas, D | 1 |
| Ellman, L | 1 |
| Inman, J | 1 |
| Green, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fasting Hypoglycemia: Diagnosis and Treatment[NCT00001276] | 1,500 participants (Anticipated) | Observational | 1991-05-21 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for hydralazine and Autoimmune Disease
| Article | Year |
|---|---|
Mechanistic Insights of Chemicals and Drugs as Risk Factors for Systemic Lupus Erythematosus.
Topics: Autoimmune Diseases; Female; Humans; Hydralazine; Lupus Erythematosus, Systemic; Procainamide; Risk | 2020 |
DNA methylation and autoimmune disease.
Topics: Animals; Autoimmune Diseases; Autoimmunity; Azacitidine; Cell Communication; DNA Methylation; Humans | 2003 |
Drug-induced lupus: an adjuvant disease?
Topics: Adjuvants, Immunologic; Animals; Autoimmune Diseases; Humans; Hydralazine; Lupus Erythematosus, Syst | 1981 |
Hydralazine-induced constrictive pericarditis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Autoantibodies; Autoimmune Diseases | 1996 |
Reactive hypoglycemic coma due to insulin autoimmune syndrome: case report and literature review.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Blood Glucose; Child, Preschool; Coma; Diagnosi | 1992 |
Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aminorex; Anticoagulants; Autoimmune Diseases; Calc | 1986 |
Drug-induced autoimmune disease.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Gold; HLA Antigens; Humans; Hydralazine; Lupus Erythemat | 1987 |
Drug-induced lupus: clinical spectrum and pathogenesis.
Topics: Acetylation; Adult; Aged; Antibodies, Antinuclear; Antibody Specificity; Autoimmune Diseases; Black | 1985 |
[Generalized lupus erythematosus caused by methyl-phenyl-ethyl-hydantoin].
Topics: Adult; Autoimmune Diseases; Female; Humans; Hydralazine; Isoniazid; Lupus Erythematosus, Systemic; M | 1967 |
[Antinuclear factors. Demonstration and clinico-diagnostic significance].
Topics: Antibodies, Antinuclear; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Chronic Disease | 1969 |
20 other studies available for hydralazine and Autoimmune Disease
| Article | Year |
|---|---|
[PROVOCATING FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS (WITH REFERENCE TO THERAPEUTIC AGENTS)].
Topics: Anticonvulsants; Antitubercular Agents; Autoimmune Diseases; Drug Hypersensitivity; Drug Therapy; Go | 1963 |
[ERYTHEMATOSUS AND AUTOIMMUNITY].
Topics: Animals; Autoantibodies; Autoimmune Diseases; Autoimmunity; DNA; Hydralazine; Lupus Erythematosus, S | 1964 |
Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosus.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Female; Glucose Tolerance Test; Humans; Hydralazine; Hypo | 1983 |
Prospective study of immunologic effects of hydralazine in hypertensive patients.
Topics: Acetylation; Adolescent; Adult; Antibodies, Antinuclear; Autoimmune Diseases; Female; Humans; Hydral | 1981 |
Drug effects on autoantibodies and immune complexes.
Topics: Acetylation; Antibodies, Antinuclear; Antigen-Antibody Complex; Arthritis, Rheumatoid; Autoantibodie | 1980 |
Immunologic effects of hydralazine in hypertensive patients.
Topics: Acetylation; Adult; Antibodies, Antinuclear; Autoimmune Diseases; Binding Sites, Antibody; Coombs Te | 1981 |
Introduction to drug-related lupus.
Topics: Acetylation; Acetyltransferases; Animals; Anticonvulsants; Autoimmune Diseases; Child; Chlorpromazin | 1981 |
Hapten immunology and allergic reactions in humans.
Topics: Animals; Autoimmune Diseases; Carrier Proteins; Drug Hypersensitivity; Environmental Health; Haptens | 1981 |
Effect of acute cytomegalovirus infection on drug-induced SLE.
Topics: Acute Disease; Autoimmune Diseases; Cytomegalovirus Infections; Disease Susceptibility; Female; Huma | 1994 |
Granulocyte autoantibodies--markers for drug-induced autoimmune adverse effects.
Topics: Antibodies, Antineutrophil Cytoplasmic; Autoantibodies; Autoimmune Diseases; Biomarkers; Glomerulone | 1993 |
Immunological side-effects of antihypertensive drugs.
Topics: Anemia, Hemolytic, Autoimmune; Antihypertensive Agents; Autoimmune Diseases; Female; Humans; Hydrala | 1979 |
ANA, DNA, and SLE.
Topics: Animals; Antibodies, Antinuclear; Autoimmune Diseases; DNA; Humans; Hydralazine; Lupus Erythematosus | 1977 |
N-acetylprocainamide is a less potent inducer of T cell autoreactivity than procainamide.
Topics: Acecainide; Autoantibodies; Autoimmune Diseases; Chromatography, High Pressure Liquid; DNA; Humans; | 1988 |
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
Topics: Autoimmune Diseases; DNA (Cytosine-5-)-Methyltransferases; Humans; Hydralazine; Immunosuppressive Ag | 1988 |
IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity.
Topics: Antibodies, Monoclonal; Autoantibodies; Autoimmune Diseases; DNA; Enzyme-Linked Immunosorbent Assay; | 1986 |
Immunologic findings in patients receiving methyldopa: a prospective study.
Topics: Acyltransferases; Antibodies, Anti-Idiotypic; Antibodies, Antinuclear; Autoimmune Diseases; Black Pe | 1971 |
Drug-induced autoimmune disease.
Topics: Acetyltransferases; Antibodies, Antinuclear; Antibody Specificity; Autoimmune Diseases; Binding Site | 1974 |
Study of autoimmune disease in New Zealand mice. II. Immunologic and parabiotic studies of NZB-NZW F1 hybrids.
Topics: Animals; Antibodies, Antinuclear; Anticonvulsants; Autoantibodies; Autoimmune Diseases; BCG Vaccine; | 1967 |
Hypersensitivity reactions.
Topics: Autoimmune Diseases; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; | 1974 |
Strain difference in the immune response to hydralazine in inbred guinea-pigs.
Topics: Animals; Antibodies; Antibodies, Antinuclear; Antibody Formation; Autoimmune Diseases; Cattle; DNA; | 1971 |